[Congressional Record Volume 170, Number 148 (Monday, September 23, 2024)]
[House]
[Pages H5576-H5577]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                        NAPA REAUTHORIZATION ACT

  Mr. BUCSHON. Mr. Speaker, I move to suspend the rules and pass the 
bill (S. 133) to extend the National Alzheimer's Project.
  The Clerk read the title of the bill.
  The text of the bill is as follows:

                                 S. 133

       Be it enacted by the Senate and House of Representatives of 
     the United States of America in Congress assembled,

     SECTION 1. SHORT TITLE.

       This Act may be cited as the ``NAPA Reauthorization Act''.

     SEC. 2. EXTENSION OF PROJECT.

       Section 2 of the National Alzheimer's Project Act (42 
     U.S.C. 11225) is amended--
       (1) in subsection (c)--
       (A) in paragraph (2), by striking ``and coordination of'' 
     and inserting ``on, and coordination of,'';
       (B) in paragraph (4)--
       (i) by redesignating subparagraphs (A) and (B) as 
     subparagraphs (B) and (C), respectively; and
       (ii) by inserting before subparagraph (B), as so 
     redesignated, the following:
       ``(A) promotion of healthy aging and reduction and 
     mitigation of risk factors for Alzheimer's;'';
       (C) in paragraph (5)--
       (i) by inserting ``and other underserved populations, 
     including individuals with developmental disabilities such as 
     Down syndrome,'' after ``populations''; and
       (ii) by striking ``; and'' and inserting a semicolon;
       (D) by redesignating paragraph (6) as paragraph (7); and
       (E) by inserting after paragraph (5) the following:
       ``(6) provide information on, and promote the adoption of, 
     healthy behaviors that may reduce the risk of cognitive 
     decline and promote and protect cognitive health; and'';
       (2) in subsection (d)(2)--
       (A) by inserting ``, across public and private sectors,'' 
     after ``Nation's progress''; and
       (B) by inserting ``, including consideration of public-
     private collaborations, as appropriate'' before the period;
       (3) in subsection (e)--
       (A) in paragraph (2)--
       (i) in subparagraph (A), by adding at the end the 
     following:

[[Page H5577]]

       ``(xi) A designee of the Department of Justice.
       ``(xii) A designee of the Federal Emergency Management 
     Agency.
       ``(xiii) A designee of the Social Security Administration.
       ``(xiv) 2 or more other designees, as determined by the 
     Secretary of Health and Human Services, at least one of whom 
     has expertise in risk factors associated with the development 
     or the progression of Alzheimer's.''; and
       (ii) in subparagraph (B)--

       (I) in the matter preceding clause (i), by striking ``12'' 
     and inserting ``15'';
       (II) in clause (v)--

       (aa) by striking ``2 researchers'' and inserting ``3 
     researchers''; and
       (bb) by striking ``; and'' and inserting ``, including at 
     least one researcher with demonstrated experience in 
     recruitment and retention of underrepresented groups into 
     research or clinical trials related to dementia;'';

       (III) in clause (vi), by striking the period and inserting 
     a semicolon; and
       (IV) by adding at the end the following:

       ``(vii) 1 individual with a diagnosis of Alzheimer's 
     disease; and
       ``(viii) 1 representative from a historically underserved 
     population whose lifetime risk for developing Alzheimer's is 
     markedly higher than that of other populations.'';
       (B) in paragraph (5)--
       (i) in subparagraph (A)--

       (I) by striking ``an initial evaluation'' and inserting 
     ``annual evaluations''; and
       (II) by striking ``research, clinical'' and inserting 
     ``research, risk reduction, public health, clinical'';

       (ii) in subparagraph (B), by striking ``initial'';
       (iii) in subparagraph (C)--

       (I) in the matter preceding clause (i), by striking 
     ``initial''; and
       (II) in clause (ii), by inserting ``and reduce 
     disparities'' before the semicolon; and

       (iv) in subparagraph (D), by striking ``annually 
     thereafter, an evaluation'' and inserting ``annual 
     evaluations''; and
       (C) in paragraph (6), by striking ``2025'' and inserting 
     ``2035'';
       (4) in subsection (g)--
       (A) in paragraph (1)--
       (i) by adding ``and'' after the semicolon;
       (ii) by striking ``that includes an evaluation'' and 
     inserting ``that includes--
       ``(A) an evaluation;''; and
       (iii) by adding at the end the following:
       ``(B) a summary of the Secretary's process for identifying 
     and updating what conditions constitute Alzheimer's 
     disease;''; and
       (B) in paragraph (3)(A)(ii), by inserting ``and reduce 
     disparities'' before the semicolon; and
       (5) in subsection (h), by striking ``2025'' and inserting 
     ``2035''.

  The SPEAKER pro tempore. Pursuant to the rule, the gentleman from 
Indiana (Mr. Bucshon) and the gentleman from New Jersey (Mr. Pallone) 
each will control 20 minutes.
  The Chair recognizes the gentleman from Indiana.


                             General Leave

  Mr. BUCSHON. Mr. Speaker, I ask unanimous consent that all Members 
may have 5 legislative days in which to revise and extend their remarks 
and include extraneous material in the Record on the bill.
  The SPEAKER pro tempore. Is there objection to the request of the 
gentleman from Indiana?
  There was no objection.
  Mr. BUCSHON. Mr. Speaker, I yield myself such time as I may consume.
  Mr. Speaker, I rise in support of S. 133, the NAPA Reauthorization 
Act led by Senators Collins and Warren.
  The House companion bill, H.R. 619, is led by Representatives Tonko 
and Smith of New Jersey.
  In the United States, one in nine people aged 65 and older currently 
suffer from Alzheimer's disease. Unfortunately, this number continues 
to grow with some estimates projecting the overall number to rise to 
12.7 million Americans by 2050.
  Congress established the National Alzheimer's Project in 2011 with a 
goal of building upon, raising awareness of, and helping to coordinate 
current Federal efforts to combat Alzheimer's disease and related 
dementia through earlier diagnosis, prevention, and improved 
treatments.
  This bill would support and improve the National Alzheimer's Project, 
including expanding membership of the advisory council to include those 
individuals battling this disease and those at high risk for developing 
Alzheimer's.
  Mr. Speaker, I encourage my colleagues to support this bill, and I 
reserve the balance of my time.
  Mr. PALLONE. Mr. Speaker, I yield myself such time as I may consume.
  Mr. Speaker, I rise in support of S. 133, the NAPA Reauthorization 
Act, which would reauthorize the National Alzheimer's Project Act 
through 2035.
  In 2011, our Nation made addressing Alzheimer's disease a priority 
when we passed the National Alzheimer's Project Act. This law called 
for a national plan to accelerate research and improve care and 
services to those living with Alzheimer's. Since the establishment of 
the national plan, we have made enormous strides in strategy 
implementation to address Alzheimer's disease and other dementia. The 
national plan has also allowed us to make progress in Alzheimer's 
research, care and services, and public awareness about the disease.
  S. 133 will build on the progress we have made through the national 
plan by reauthorizing the law through fiscal year 2035. The bill will 
also allow the national plan to address healthy aging and risk 
reduction issues related to Alzheimer's disease.
  This reauthorization will build on the progress brought forward by 
NAPA and allow the Department of Health and Human Services to continue 
long-term planning for a strategic approach to addressing Alzheimer's 
and other dementia.
  This bill is the Senate counterpart of legislation led by 
Representative Tonko, who shepherded this bipartisan reauthorization 
through the Energy and Commerce Committee this past spring. Since the 
beginning of his time in Congress, Representative Tonko has led the 
push to address Alzheimer's and related dementia, and I thank him for 
his continued leadership.
  I also thank my colleague from New Jersey, Representative Smith, who 
is the Republican sponsor.
  I encourage my colleagues to vote ``yes'' on S. 133 so we can 
continue our commitment to combat Alzheimer's disease.
  Mr. Speaker, I reserve the balance of my time.
  Mr. BUCSHON. Mr. Speaker, I yield 5 minutes to the gentleman from 
Georgia (Mr. Carter).
  Mr. CARTER of Georgia. Mr. Speaker, I thank the gentleman for 
yielding.
  Mr. Speaker, I am proud to join my colleagues in supporting the 
National Alzheimer's Project Reauthorization Act.
  This legislation reauthorizes the National Alzheimer's Project Act 
through 2035, providing a roadmap for Federal efforts in responding to 
Alzheimer's and dementia.
  Alzheimer's is a cruel disease that steals a person's quality of 
life. As a pharmacist, I have seen firsthand the impact Alzheimer's and 
other forms of dementia have on patients, families, caregivers, and 
society overall.
  People living with Alzheimer's lose their memories, their 
independence, their relationships, and ultimately their lives. Beyond 
the patients, caregivers and loved ones endure emotional distress and 
unthinkable financial burdens.
  With nearly 7 million Americans suffering with Alzheimer's, there is 
a critical need for Federal resources to prevent, treat, and ultimately 
find a cure for this devastating disease.
  In honor of those who have battled and continue to battle this 
disease, let's continue to work together to raise awareness and pass 
this bill.
  Mr. PALLONE. Mr. Speaker, I urge all of us to support this bill on a 
bipartisan basis. Whatever we can do to fight Alzheimer's is very 
important.
  Mr. Speaker, I yield back the balance of my time.
  Mr. BUCSHON. Mr. Speaker, in closing, I encourage a ``yes'' vote on 
this bill, and I yield back the balance of my time.
  The SPEAKER pro tempore. The question is on the motion offered by the 
gentleman from Indiana (Mr. Bucshon) that the House suspend the rules 
and pass the bill, S. 133.
  The question was taken; and (two-thirds being in the affirmative) the 
rules were suspended and the bill was passed.
  A motion to reconsider was laid on the table.

                          ____________________